High-Margin Medical Device Distributor with Exclusive Rights and Recurring Revenue in Texas

This is a rare opportunity to acquire a growing, high-margin distributor holding exclusive U.S. distribution rights for FDA-cleared consumable medical devices used in Platelet-Rich Plasma (PRP) therapy for regenerative medicine. The business demonstrates robust financial health with gross margins exceeding 75% and EBITDA margins around 30%. Revenue stability is high, driven by over 80% repeat customer sales. The sector is experiencing double-digit CAGR growth. The current owners are retiring and will provide comprehensive transition support.